Annual CFF:
$27.01M-$175.74M(-86.68%)Summary
- As of today, KRYS annual cash from financing is $27.01 million, with the most recent change of -$175.74 million (-86.68%) on December 31, 2024.
- During the last 3 years, KRYS annual cash from financing has fallen by -$320.67 million (-92.23%).
- KRYS annual cash from financing is now -92.23% below its all-time high of $347.69 million, reached on December 31, 2021.
Performance
KRYS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$1.80M+$14.26M(+114.41%)Summary
- As of today, KRYS quarterly cash from financing is $1.80 million, with the most recent change of +$14.26 million (+114.41%) on June 30, 2025.
- Over the past year, KRYS quarterly cash from financing has dropped by -$8.84 million (-83.12%).
- KRYS quarterly cash from financing is now -99.11% below its all-time high of $202.07 million, reached on December 31, 2021.
Performance
KRYS Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$4.88M-$8.84M(-223.00%)Summary
- As of today, KRYS TTM cash from financing is -$4.88 million, with the most recent change of -$8.84 million (-223.00%) on June 30, 2025.
- Over the past year, KRYS TTM cash from financing has dropped by -$42.10 million (-113.10%).
- KRYS TTM cash from financing is now -101.40% below its all-time high of $347.69 million, reached on December 31, 2021.
Performance
KRYS TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KRYS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -86.7% | -83.1% | -113.1% |
| 3Y3 Years | -92.2% | -94.2% | -102.1% |
| 5Y5 Years | -74.9% | -98.5% | -104.1% |
KRYS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -92.2% | at low | -99.0% | +114.4% | -102.1% | at low |
| 5Y | 5-Year | -92.2% | at low | -99.1% | +114.4% | -101.4% | at low |
| All-Time | All-Time | -92.2% | +731.5% | -99.1% | +114.4% | -101.4% | at low |
KRYS Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.80M(+114.4%) | -$4.88M(-223.0%) |
| Mar 2025 | - | -$12.47M(-613.4%) | $3.96M(-85.3%) |
| Dec 2024 | $27.01M(-86.7%) | $2.43M(-27.8%) | $27.01M(-0.7%) |
| Sep 2024 | - | $3.37M(-68.4%) | $27.20M(-26.9%) |
| Jun 2024 | - | $10.64M(+0.5%) | $37.23M(-82.4%) |
| Mar 2024 | - | $10.58M(+304.1%) | $211.86M(+4.5%) |
| Dec 2023 | $202.75M(+473.6%) | $2.62M(-80.4%) | $202.75M(-0.2%) |
| Sep 2023 | - | $13.39M(-92.8%) | $203.20M(+5.9%) |
| Jun 2023 | - | $185.27M(>+9900.0%) | $191.93M(+413.7%) |
| Mar 2023 | - | $1.47M(-52.0%) | $37.36M(+5.7%) |
| Dec 2022 | $35.35M(-89.8%) | $3.07M(+44.8%) | $35.35M(-84.9%) |
| Sep 2022 | - | $2.12M(-93.1%) | $234.35M(+0.3%) |
| Jun 2022 | - | $30.70M(+5764.2%) | $233.74M(+15.2%) |
| Mar 2022 | - | -$542.00K(-100.3%) | $202.84M(-41.7%) |
| Dec 2021 | $347.69M(+194.6%) | $202.07M(>+9900.0%) | $347.69M(+138.5%) |
| Sep 2021 | - | $1.51M(+857.8%) | $145.75M(+0.9%) |
| Jun 2021 | - | -$199.00K(-100.1%) | $144.41M(-44.9%) |
| Mar 2021 | - | $144.30M(>+9900.0%) | $262.08M(+122.1%) |
| Dec 2020 | $118.02M | $141.00K(-15.1%) | $118.02M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $166.00K(-99.9%) | $118.18M(-9.9%) |
| Jun 2020 | - | $117.47M(>+9900.0%) | $131.18M(+21.8%) |
| Mar 2020 | - | $243.00K(-18.7%) | $107.73M(+0.2%) |
| Dec 2019 | $107.53M(+45.6%) | $299.00K(-97.7%) | $107.53M(-37.3%) |
| Sep 2019 | - | $13.17M(-86.0%) | $171.51M(+2.2%) |
| Jun 2019 | - | $94.02M(>+9900.0%) | $167.90M(+127.3%) |
| Mar 2019 | - | $40.00K(-99.9%) | $73.88M(+0.0%) |
| Dec 2018 | $73.85M(+42.6%) | $64.29M(+573.2%) | $73.85M(+732.9%) |
| Sep 2018 | - | $9.55M(>+9900.0%) | $8.87M(-82.1%) |
| Jun 2018 | - | $4000.00(-33.3%) | $49.48M(-3.9%) |
| Mar 2018 | - | $6000.00(+100.9%) | $51.47M(-0.6%) |
| Dec 2017 | $51.77M(+1493.4%) | -$693.00K(-101.4%) | $51.77M(-5.6%) |
| Sep 2017 | - | $50.16M(+2409.4%) | $54.86M(+1068.6%) |
| Jun 2017 | - | $2.00M(+566.3%) | $4.69M(+36.1%) |
| Mar 2017 | - | $300.00K(-87.5%) | $3.45M(+6.2%) |
| Dec 2016 | $3.25M | $2.40M(>+9900.0%) | $3.25M(+280.4%) |
| Sep 2016 | - | $0.00(-100.0%) | $854.00K(0.0%) |
| Jun 2016 | - | $754.00K(+654.0%) | $854.00K(+754.0%) |
| Mar 2016 | - | $100.00K | $100.00K |
FAQ
- What is Krystal Biotech, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. annual cash from financing year-on-year change?
- What is Krystal Biotech, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. quarterly cash from financing year-on-year change?
- What is Krystal Biotech, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. TTM cash from financing year-on-year change?
What is Krystal Biotech, Inc. annual cash from financing?
The current annual cash from financing of KRYS is $27.01M
What is the all-time high annual cash from financing for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high annual cash from financing is $347.69M
What is Krystal Biotech, Inc. annual cash from financing year-on-year change?
Over the past year, KRYS annual cash from financing has changed by -$175.74M (-86.68%)
What is Krystal Biotech, Inc. quarterly cash from financing?
The current quarterly cash from financing of KRYS is $1.80M
What is the all-time high quarterly cash from financing for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high quarterly cash from financing is $202.07M
What is Krystal Biotech, Inc. quarterly cash from financing year-on-year change?
Over the past year, KRYS quarterly cash from financing has changed by -$8.84M (-83.12%)
What is Krystal Biotech, Inc. TTM cash from financing?
The current TTM cash from financing of KRYS is -$4.88M
What is the all-time high TTM cash from financing for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high TTM cash from financing is $347.69M
What is Krystal Biotech, Inc. TTM cash from financing year-on-year change?
Over the past year, KRYS TTM cash from financing has changed by -$42.10M (-113.10%)